Ford expands U.S. medical ride business built around its vans
DETROIT (Reuters) – Ford Motor Co (F.N) said on Wednesday that it was expanding a medical transport service called GoRide in Southeast Michigan, one of several efforts by the U.S.…
Global leaders seek to reignite fight against deadly malaria
LONDON, April 18 (Reuters) – Renewed action and boosted funding to fight malaria could prevent 350 million cases of the disease in the next five years and save 650,000 lives…
Canada seeks U.S. help to solve EpiPen shortage
TORONTO (Reuters) – Canada said on Tuesday it is working with the U.S. Food and Drug Administration to access supplies of Mylan N.V.’s EpiPen emergency allergy antidote amid a growing…
Wall Street rises on earnings hopes, Netflix soars
NEW YORK (Reuters) – U.S. stock indexes rallied on Tuesday on broad-based gains while Netflix and UnitedHealth earnings impressed investors and boosted optimism about the U.S. corporate reporting season. Shares…
FDA approves Ultragenyx’s drug for rare form of rickets
(Reuters) – The U.S. Food and Drug Administration has approved Ultragenyx Pharmaceutical Inc’s treatment for a rare and inherited form of rickets, a condition that causes weak bones, the agency…
U.S. bans American companies from selling to Chinese phone maker ZTE
LONDON/NEW YORK (Reuters) – The U.S. Department of Commerce has banned American companies from selling components to Chinese telecom equipment maker ZTE Corp for seven years after breaking an agreement…
Sen. McCain has intestinal surgery, is recovering in Phoenix
Interested in John McCain? Add John McCain as an interest to stay up to date on the latest John McCain news, video, and analysis from ABC News. U.S. Sen. John…
China tariffs on U.S. business jets no clear boost to rivals: aviation executives
SHANGHAI (Reuters) – China’s planned tariffs on U.S. business jets may do little to buoy rivals despite concerns the moves could create an unequal playing field in the fast-growing China…
J&J Baby Powder litigation takes new focus with asbestos claims
NEW YORK (Reuters) – A $117 million verdict against Johnson & Johnson (JNJ.N) and a supplier in favor of a man who said his asbestos-related cancer was caused by long-term…
ECB asks Deutsche Bank to gauge investment banking exit costs: source
FRANKFURT (Reuters) – Deutsche Bank (DBKGn.DE) has been asked by European Central Bank supervisors to calculate the potential costs of winding down its investment banking operations, a source told Reuters…